Playback speed
10 seconds
ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial
By
ACC 2023 Conference Coverage
FEATURING
Barry Borlaug
By
ACC 2023 Conference Coverage
FEATURING
Barry Borlaug
1,317 views
March 15, 2023
Login to view comments.
Click here to Login